Table 3.

The Average Blood Pressure and the Percent of Patients Under Control in Various Subgroups

GroupsBaseline*After 30 Months’ Follow-up
Patients (n)Systolic BPDiastolic BPSystolic BPChange in Systolic BPDiastolic BPChange in Diastolic BPPatients Under Control (%)
Total25117095140−3082−1359
Male6717398136−3780−1866
Female18416994141−2883−1156
Age <6012316695139−2782−1364
Age ≥6012817496142−3283−1353
Stage I of hypertension8115289138−1481−868
Stage II of hypertension (JNC VI)10216893139−2981−1263
Stage III of hypertension (JNC VI)68194106145−4985−2141
Isolated systolic hypertension6315884139−1983−174
Systolic BP ≥20025213112150−6387−2520
Diastolic BP ≥11027201112152−4988−2417
Patients with major comorbid conditions6817298148−2486−1230
  • Blood pressure values presented as mm Hg. BP, blood pressure; JNC VI, Joint National Committee VI.

  • * Baseline data are for all patients before the treatment; data shown in the category “After 30 Months’ Follow-up” are for those who continued participation after 30 months of follow-up.

  • Blood pressure less than 140/90 mm Hg was considered as hypertension control.

  • Major comorbid conditions include congestive heart failure, stroke, myocardial infarction, diabetes, peripheral vascular diseases, and renal diseases.

  • This table has been reprinted with permission.